Abstract
Screen-detected breast cancers are smaller than those detected in symptomatic populations and, for any given size, they are associated with fewer lymph node metastases. The management of axillary lymph nodes in patients with screen-detected breast cancer remains controversial. We have previously reported that prevalence (initial screen)-detected cancers are associated with nodal metastases in 17.4% of cases overall. Cancers < or = 10 mm, of any grade, are associated with metastases in only 5% of cases, and grade I cancers <30 mm are not associated with metastases. This led to our recommendation that axillary surgery is unnecessary for these groups of women. The present study compared the nodal status of cancers detected at the prevalence and first incidence (second) screens in order to determine whether our recommendation is appropriate for cancers detected at the first incidence screen. Overall, 30.1% of cancers detected in the first incidence screen presented axillary nodal metastases. At all size ranges, cancers detected at the first incidence screen were associated with significantly more lymph node metastases than prevalence-detected cancers. In particular, cancers < or = 10 mm were associated with metastases in 14.3% of cases. With the possible exception of grade I cancers, we believe that surgical staging of the axilla is essential for cancers detected at the first incidence screen, irrespective of size.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holland, P., Walls, J., Boggis, C. et al. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer 74, 1643–1646 (1996). https://doi.org/10.1038/bjc.1996.602
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.602
This article is cited by
-
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Breast Cancer Research and Treatment (2013)
-
Preoperative selection of symptomatic breast cancer patients appropriate for lymphatic mapping and sentinel node biopsy
Irish Journal of Medical Science (2007)
-
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer
Oncogene (2005)
-
Factors Correlating With Lymph Node Metastases in Patients With T1 Breast Cancer
Annals of Surgical Oncology (2001)
-
Management of the axillary nodes
Breast Cancer (1999)